Zu "2805997-46-8" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
NEU
Survodutide
Artikelnummer: AG-CP3-0046-M001
Survodutide is a novel long-acting dual glucagon-like peptide-1 (GLP-1) receptor and glucagon receptor (GCGR) agonist. Survodutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GCG receptor (GCGR) or the GLP-1R. Survodutide is a synthetic...
| Schlagworte: | BI-456906, EX-A7878, GTPL13383 |
| Anwendung: | Long-acting dual glucagon-like peptide-1 (GLP-1) receptor / glucagon receptor (GCGR) agonist |
| CAS | 2805997-46-8 |
| MW: | 4231,7 D |
ab 66,00 €
Survodutide
Artikelnummer: TGM-T76559-10mg
Description: Survodutide (BI 456906) is a dual agonist of glucagon and glucagon-like peptide 1 (GLP-1) receptors (GLP Receptor) that reduces body weight in HbA1c16 diabetes. Target: Glucagon Receptor. References: Blüher M,et al. Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual...
| Schlagworte: | BI 456906 |
| Anwendung: | Targets glucagon-like peptide 1 receptor (GLP1R) |
| CAS | 2805997-46-8 |
| MW: | 4231.62 D |
ab 105,00 €
Survodutide
Artikelnummer: Cay40972-1
Survodutide is a dual peptide agonist of the glucagon-like peptide 1 receptor (GLP-1R) and glucagon receptor (GCGR). It increases cAMP accumulation in CHO-K1 cells expressing GLP-1R or GCGR in reporter assays (EC50s = 0.33 and 0.52 nM, respectively) and potentiates glucose-induced insulin secretion in isolated...
| Schlagworte: | BI-456906,... |
| Anwendung: | GLP-1R / GCGR dual peptide agonist |
| CAS | 2805997-46-8 |
| MW: | 4231.7 D |
ab 90,00 €
